Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis

Claire F. McGroder, Carrie P. Aaron, Suzette J. Bielinski, Steven M. Kawut, Russell P. Tracy, Ganesh Raghu, R. Graham Barr, David J. Lederer, Anna J. Podolanczuk

Research output: Contribution to journalArticle

Abstract

Adhesion molecules may contribute to the development of interstitial lung disease (ILD) and have been proposed as prognostic biomarkers in idiopathic pulmonary fibrosis. Our objective was to determine whether the circulating adhesion molecules soluble intracellular adhesion molecule (sICAM)-1, soluble vascular cell adhesion molecule (sVCAM)-1 and P-selectin are associated with subclinical ILD in community-dwelling adults.The Multi-Ethnic Study of Atherosclerosis enrolled males and females aged 45-84 years from six communities in the United States in 2000-2002. High attenuation areas were defined as the percentage of imaged lung volume with attenuation -600--250 HU on cardiac computed tomography (CT). Interstitial lung abnormalities were visually assessed on full-lung CT. Spirometry was performed on a subset of individuals. ILD hospitalisations and deaths were adjudicated.In fully adjusted analyses, higher levels of sICAM-1, sVCAM-1 and P-selectin were associated with greater high attenuation areas (2.94%, 95% CI 1.80-4.07%; 1.24%, 95% CI 0.14-2.35%; and 1.58%, 95% CI 0.92-2.23%, respectively), and greater rate of ILD hospitalisations (HR 1.36, 95% CI 1.03-1.80; 1.40, 95% CI 1.07-1.85; and 2.03, 95% CI 1.16-3.5, respectively). sICAM-1 was associated with greater prevalence of interstitial lung abnormalities (OR 1.39, 95% CI 1.13-1.71). sICAM-1 and P-selectin were associated with lower forced vital capacity (44 mL, 95% CI 12-76 mL and 29 mL, 95% CI 8-49 mL, respectively). sVCAM-1 and P-selectin were associated with increased risk of ILD death (HR 2.15, 95% CI 1.26-3.64 and 3.61, 95% CI 1.54-8.46, respectively).Higher levels of circulating sICAM-1, sVCAM-1 and P-selectin are independently associated with CT and spirometric measures of subclinical ILD, and increased rate of adjudicated ILD events among community-dwelling adults.

Original languageEnglish (US)
JournalThe European respiratory journal
Volume54
Issue number3
DOIs
StatePublished - Sep 1 2019

Fingerprint

Interstitial Lung Diseases
P-Selectin
Atherosclerosis
Vascular Cell Adhesion Molecule-1
Independent Living
Lung
Tomography
Hospitalization
Idiopathic Pulmonary Fibrosis
Spirometry
Vital Capacity
Biomarkers

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Circulating adhesion molecules and subclinical interstitial lung disease : the Multi-Ethnic Study of Atherosclerosis. / McGroder, Claire F.; Aaron, Carrie P.; Bielinski, Suzette J.; Kawut, Steven M.; Tracy, Russell P.; Raghu, Ganesh; Barr, R. Graham; Lederer, David J.; Podolanczuk, Anna J.

In: The European respiratory journal, Vol. 54, No. 3, 01.09.2019.

Research output: Contribution to journalArticle

McGroder, Claire F. ; Aaron, Carrie P. ; Bielinski, Suzette J. ; Kawut, Steven M. ; Tracy, Russell P. ; Raghu, Ganesh ; Barr, R. Graham ; Lederer, David J. ; Podolanczuk, Anna J. / Circulating adhesion molecules and subclinical interstitial lung disease : the Multi-Ethnic Study of Atherosclerosis. In: The European respiratory journal. 2019 ; Vol. 54, No. 3.
@article{005e0bf7f1f54c5c82464a4c362bc09d,
title = "Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis",
abstract = "Adhesion molecules may contribute to the development of interstitial lung disease (ILD) and have been proposed as prognostic biomarkers in idiopathic pulmonary fibrosis. Our objective was to determine whether the circulating adhesion molecules soluble intracellular adhesion molecule (sICAM)-1, soluble vascular cell adhesion molecule (sVCAM)-1 and P-selectin are associated with subclinical ILD in community-dwelling adults.The Multi-Ethnic Study of Atherosclerosis enrolled males and females aged 45-84 years from six communities in the United States in 2000-2002. High attenuation areas were defined as the percentage of imaged lung volume with attenuation -600--250 HU on cardiac computed tomography (CT). Interstitial lung abnormalities were visually assessed on full-lung CT. Spirometry was performed on a subset of individuals. ILD hospitalisations and deaths were adjudicated.In fully adjusted analyses, higher levels of sICAM-1, sVCAM-1 and P-selectin were associated with greater high attenuation areas (2.94{\%}, 95{\%} CI 1.80-4.07{\%}; 1.24{\%}, 95{\%} CI 0.14-2.35{\%}; and 1.58{\%}, 95{\%} CI 0.92-2.23{\%}, respectively), and greater rate of ILD hospitalisations (HR 1.36, 95{\%} CI 1.03-1.80; 1.40, 95{\%} CI 1.07-1.85; and 2.03, 95{\%} CI 1.16-3.5, respectively). sICAM-1 was associated with greater prevalence of interstitial lung abnormalities (OR 1.39, 95{\%} CI 1.13-1.71). sICAM-1 and P-selectin were associated with lower forced vital capacity (44 mL, 95{\%} CI 12-76 mL and 29 mL, 95{\%} CI 8-49 mL, respectively). sVCAM-1 and P-selectin were associated with increased risk of ILD death (HR 2.15, 95{\%} CI 1.26-3.64 and 3.61, 95{\%} CI 1.54-8.46, respectively).Higher levels of circulating sICAM-1, sVCAM-1 and P-selectin are independently associated with CT and spirometric measures of subclinical ILD, and increased rate of adjudicated ILD events among community-dwelling adults.",
author = "McGroder, {Claire F.} and Aaron, {Carrie P.} and Bielinski, {Suzette J.} and Kawut, {Steven M.} and Tracy, {Russell P.} and Ganesh Raghu and Barr, {R. Graham} and Lederer, {David J.} and Podolanczuk, {Anna J.}",
year = "2019",
month = "9",
day = "1",
doi = "10.1183/13993003.00295-2019",
language = "English (US)",
volume = "54",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "3",

}

TY - JOUR

T1 - Circulating adhesion molecules and subclinical interstitial lung disease

T2 - the Multi-Ethnic Study of Atherosclerosis

AU - McGroder, Claire F.

AU - Aaron, Carrie P.

AU - Bielinski, Suzette J.

AU - Kawut, Steven M.

AU - Tracy, Russell P.

AU - Raghu, Ganesh

AU - Barr, R. Graham

AU - Lederer, David J.

AU - Podolanczuk, Anna J.

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Adhesion molecules may contribute to the development of interstitial lung disease (ILD) and have been proposed as prognostic biomarkers in idiopathic pulmonary fibrosis. Our objective was to determine whether the circulating adhesion molecules soluble intracellular adhesion molecule (sICAM)-1, soluble vascular cell adhesion molecule (sVCAM)-1 and P-selectin are associated with subclinical ILD in community-dwelling adults.The Multi-Ethnic Study of Atherosclerosis enrolled males and females aged 45-84 years from six communities in the United States in 2000-2002. High attenuation areas were defined as the percentage of imaged lung volume with attenuation -600--250 HU on cardiac computed tomography (CT). Interstitial lung abnormalities were visually assessed on full-lung CT. Spirometry was performed on a subset of individuals. ILD hospitalisations and deaths were adjudicated.In fully adjusted analyses, higher levels of sICAM-1, sVCAM-1 and P-selectin were associated with greater high attenuation areas (2.94%, 95% CI 1.80-4.07%; 1.24%, 95% CI 0.14-2.35%; and 1.58%, 95% CI 0.92-2.23%, respectively), and greater rate of ILD hospitalisations (HR 1.36, 95% CI 1.03-1.80; 1.40, 95% CI 1.07-1.85; and 2.03, 95% CI 1.16-3.5, respectively). sICAM-1 was associated with greater prevalence of interstitial lung abnormalities (OR 1.39, 95% CI 1.13-1.71). sICAM-1 and P-selectin were associated with lower forced vital capacity (44 mL, 95% CI 12-76 mL and 29 mL, 95% CI 8-49 mL, respectively). sVCAM-1 and P-selectin were associated with increased risk of ILD death (HR 2.15, 95% CI 1.26-3.64 and 3.61, 95% CI 1.54-8.46, respectively).Higher levels of circulating sICAM-1, sVCAM-1 and P-selectin are independently associated with CT and spirometric measures of subclinical ILD, and increased rate of adjudicated ILD events among community-dwelling adults.

AB - Adhesion molecules may contribute to the development of interstitial lung disease (ILD) and have been proposed as prognostic biomarkers in idiopathic pulmonary fibrosis. Our objective was to determine whether the circulating adhesion molecules soluble intracellular adhesion molecule (sICAM)-1, soluble vascular cell adhesion molecule (sVCAM)-1 and P-selectin are associated with subclinical ILD in community-dwelling adults.The Multi-Ethnic Study of Atherosclerosis enrolled males and females aged 45-84 years from six communities in the United States in 2000-2002. High attenuation areas were defined as the percentage of imaged lung volume with attenuation -600--250 HU on cardiac computed tomography (CT). Interstitial lung abnormalities were visually assessed on full-lung CT. Spirometry was performed on a subset of individuals. ILD hospitalisations and deaths were adjudicated.In fully adjusted analyses, higher levels of sICAM-1, sVCAM-1 and P-selectin were associated with greater high attenuation areas (2.94%, 95% CI 1.80-4.07%; 1.24%, 95% CI 0.14-2.35%; and 1.58%, 95% CI 0.92-2.23%, respectively), and greater rate of ILD hospitalisations (HR 1.36, 95% CI 1.03-1.80; 1.40, 95% CI 1.07-1.85; and 2.03, 95% CI 1.16-3.5, respectively). sICAM-1 was associated with greater prevalence of interstitial lung abnormalities (OR 1.39, 95% CI 1.13-1.71). sICAM-1 and P-selectin were associated with lower forced vital capacity (44 mL, 95% CI 12-76 mL and 29 mL, 95% CI 8-49 mL, respectively). sVCAM-1 and P-selectin were associated with increased risk of ILD death (HR 2.15, 95% CI 1.26-3.64 and 3.61, 95% CI 1.54-8.46, respectively).Higher levels of circulating sICAM-1, sVCAM-1 and P-selectin are independently associated with CT and spirometric measures of subclinical ILD, and increased rate of adjudicated ILD events among community-dwelling adults.

UR - http://www.scopus.com/inward/record.url?scp=85072791249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072791249&partnerID=8YFLogxK

U2 - 10.1183/13993003.00295-2019

DO - 10.1183/13993003.00295-2019

M3 - Article

C2 - 31371443

AN - SCOPUS:85072791249

VL - 54

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 3

ER -